These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 8872147)
1. Expression of beta-catenin in normal breast tissue and breast carcinoma: a comparative study with epithelial cadherin and alpha-catenin. Hashizume R; Koizumi H; Ihara A; Ohta T; Uchikoshi T Histopathology; 1996 Aug; 29(2):139-46. PubMed ID: 8872147 [TBL] [Abstract][Full Text] [Related]
2. Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. De Leeuw WJ; Berx G; Vos CB; Peterse JL; Van de Vijver MJ; Litvinov S; Van Roy F; Cornelisse CJ; Cleton-Jansen AM J Pathol; 1997 Dec; 183(4):404-11. PubMed ID: 9496256 [TBL] [Abstract][Full Text] [Related]
3. Immunophenotypic and prognostic analysis of E-cadherin and beta-catenin expression during breast carcinogenesis and tumour progression: a comparative study with CD44. Bànkfalvi A; Terpe HJ; Breukelmann D; Bier B; Rempe D; Pschadka G; Krech R; Lellè RJ; Boecker W Histopathology; 1999 Jan; 34(1):25-34. PubMed ID: 9934581 [TBL] [Abstract][Full Text] [Related]
4. E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma. Bukholm IK; Nesland JM; Kåresen R; Jacobsen U; Børresen-Dale AL J Pathol; 1998 Jul; 185(3):262-6. PubMed ID: 9771479 [TBL] [Abstract][Full Text] [Related]
5. [E-cadherin associated protein expression and its significance in invasive lobular carcinoma and invasive ductal carcinoma of breast]. Han A; Xiong M; Li Z; Liang Y Zhonghua Bing Li Xue Za Zhi; 2001 Feb; 30(1):27-30. PubMed ID: 11866953 [TBL] [Abstract][Full Text] [Related]
6. Expression of E-cadherin, alpha-catenin and beta-catenin in normal ovarian surface epithelium and epithelial ovarian cancers. Davies BR; Worsley SD; Ponder BA Histopathology; 1998 Jan; 32(1):69-80. PubMed ID: 9522220 [TBL] [Abstract][Full Text] [Related]
7. [Expression of cell adhesion molecules E-cadherin and beta-catenin in infiltrating breast carcinoma]. Chipysheva TA; Gel'shteĭn VI; Ermilova VD; Vishnevskaia IaV; Vasil'ev IuM Arkh Patol; 2003; 65(3):3-7. PubMed ID: 12879601 [TBL] [Abstract][Full Text] [Related]
8. Significance of E-cadherin/beta-catenin complex and cyclin D1 in breast cancer. Lim SC; Lee MS Oncol Rep; 2002; 9(5):915-28. PubMed ID: 12168049 [TBL] [Abstract][Full Text] [Related]
9. Expression patterns of beta-catenin in in situ and invasive breast cancer. Karayiannakis AJ; Nakopoulou L; Gakiopoulou H; Keramopoulos A; Davaris PS; Pignatelli M Eur J Surg Oncol; 2001 Feb; 27(1):31-6. PubMed ID: 11237489 [TBL] [Abstract][Full Text] [Related]
10. An immunohistochemical examination of the expression of E-cadherin, alpha- and beta/gamma-catenins, and alpha2- and beta1-integrins in invasive breast cancer. Gonzalez MA; Pinder SE; Wencyk PM; Bell JA; Elston CW; Nicholson RI; Robertson JF; Blamey RW; Ellis IO J Pathol; 1999 Apr; 187(5):523-9. PubMed ID: 10398116 [TBL] [Abstract][Full Text] [Related]
11. c-met tyrosine kinase receptor expression is associated with abnormal beta-catenin expression and favourable prognostic factors in invasive breast carcinoma. Nakopoulou L; Gakiopoulou H; Keramopoulos A; Giannopoulou I; Athanassiadou P; Mavrommatis J; Davaris PS Histopathology; 2000 Apr; 36(4):313-25. PubMed ID: 10759945 [TBL] [Abstract][Full Text] [Related]
12. Clinical significance of E-cadherin-catenin complex expression in metastatic foci of colorectal carcinoma. Ikeguchi M; Makino M; Kaibara N J Surg Oncol; 2001 Jul; 77(3):201-7. PubMed ID: 11455558 [TBL] [Abstract][Full Text] [Related]
13. Immunohistochemical patterns for alpha- and beta-catenin, E- and N-cadherin expression in ovarian epithelial tumors. Marques FR; Fonsechi-Carvasan GA; De Angelo Andrade LA; Böttcher-Luiz F Gynecol Oncol; 2004 Jul; 94(1):16-24. PubMed ID: 15262114 [TBL] [Abstract][Full Text] [Related]
14. P-cadherin expression in breast carcinoma indicates poor survival. Peralta Soler A; Knudsen KA; Salazar H; Han AC; Keshgegian AA Cancer; 1999 Oct; 86(7):1263-72. PubMed ID: 10506713 [TBL] [Abstract][Full Text] [Related]
15. Expression of E-cadherin and catenins in invasive mammary carcinomas. Zschiesche W; Schönborn I; Behrens J; Herrenknecht K; Hartveit F; Lilleng P; Birchmeier W Anticancer Res; 1997; 17(1B):561-7. PubMed ID: 9066580 [TBL] [Abstract][Full Text] [Related]
16. Expression of E-cadherin, alpha-catenin, and beta-catenin in tubulolobular carcinoma of the breast. Kuroda H; Tamaru J; Takeuchi I; Ohnisi K; Sakamoto G; Adachi A; Kaneko K; Itoyama S Virchows Arch; 2006 Apr; 448(4):500-5. PubMed ID: 16538444 [TBL] [Abstract][Full Text] [Related]
17. Immunolocalization of the fodrin, E-cadherin, and beta-catenin adhesion complex in infiltrating ductal carcinoma of the breast-comparison with an in vitro model. Sormunen RT; Leong AS; Vääräniemi JP; Fernando SS; Eskelinen SM J Pathol; 1999 Mar; 187(4):416-23. PubMed ID: 10398100 [TBL] [Abstract][Full Text] [Related]
18. The loss of E-cadherin, alpha- and beta-catenin expression is associated with metastasis and poor prognosis in invasive breast cancer. Yoshida R; Kimura N; Harada Y; Ohuchi N Int J Oncol; 2001 Mar; 18(3):513-20. PubMed ID: 11179480 [TBL] [Abstract][Full Text] [Related]
19. Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis. Park D; Kåresen R; Axcrona U; Noren T; Sauer T APMIS; 2007 Jan; 115(1):52-65. PubMed ID: 17223851 [TBL] [Abstract][Full Text] [Related]
20. Downregulation and abnormal expression of E-cadherin and beta-catenin in nasopharyngeal carcinoma: close association with advanced disease stage and lymph node metastasis. Zheng Z; Pan J; Chu B; Wong YC; Cheung AL; Tsao SW Hum Pathol; 1999 Apr; 30(4):458-66. PubMed ID: 10208469 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]